Patents by Inventor Jinghong DONG

Jinghong DONG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Bicyclic compound that acts as CRBN protein regulator
    Patent number: 11905276
    Abstract: A compound represented by formula (III) or a pharmaceutically acceptable salt thereof, and disclosed is an application thereof in the preparation of a medication for treating diseases related to a CRBN receptor.
    Type: Grant
    Filed: September 14, 2020
    Date of Patent: February 20, 2024
    Assignee: MEDSHINE DISCOVERY INC.
    Inventors: Yunfu Luo, Maoyi Lei, Yu Xu, Junmiao Li, Guoli Zhang, Jinghong Dong, Shuhui Chen
  • BICYCLIC COMPOUND THAT ACTS AS CRBN PROTEIN REGULATOR
    Publication number: 20230348441
    Abstract: A compound represented by formula (III) or a pharmaceutically acceptable salt thereof, and disclosed is an application thereof in the preparation of a medication for treating diseases related to a CRBN receptor.
    Type: Application
    Filed: September 14, 2020
    Publication date: November 2, 2023
    Inventors: Yunfu LUO, Maoyi LEI, Yu XU, Junmiao LI, Guoli ZHANG, Jinghong DONG, Shuhui CHEN
  • Tricyclic furan-substituted piperidinedione compound
    Patent number: 11319330
    Abstract: Disclosed are a series of tricyclic furan-substituted piperidinedione compounds and an application thereof in preparing a drug for treating a disease related to CRBN protein. In particular, disclosed is a derivative compound represented by formula (I) or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: September 9, 2019
    Date of Patent: May 3, 2022
    Assignee: MEDSHINE DISCOVERY INC.
    Inventors: Maoyi Lei, Yunfu Luo, Yu Xu, Guoli Zhang, Jinghong Dong, Jian Li, Shuhui Chen
  • TRICYCLIC FURAN-SUBSTITUTED PIPERIDINEDIONE COMPOUND
    Publication number: 20210317138
    Abstract: Disclosed are a series of tricyclic furan-substituted piperidinedione compounds and an application thereof in preparing a drug for treating a disease related to CRBN protein. In particular, disclosed is a derivative compound represented by formula (I) or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: September 9, 2019
    Publication date: October 14, 2021
    Inventors: Maoyi LEI, Yunfu LUO, Yu XU, Guoli ZHANG, Jinghong DONG, Jian LI, Shuhui CHEN